Breakpoint Therapeutics
PrivateLast Round
Series A
Extension
Oct 18, 2021
Total Funding Raised
$33.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Breakpoint Therapeutics is a biotechnology company that discovers and develops anti-cancer drugs targeting DNA damage response mechanisms in cancer cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Breakpoint Therapeutics Comparables
Compare Breakpoint Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FoRx Therapeutics | 86% | |
| CV6 Therapeutics | 84% | |
| SynRx Therapeutics | 84% |
Breakpoint Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 18, 2021 | ||||
| Series A | Jul 8, 2019 |
Breakpoint Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiho Ventures | Series A |
| BVF Partners L.P. | Series A Extension |
| Medicxi | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 732% MoM, from 99 to 824.
- May 15, 2026
Monthly visitors grew 315% MoM, from 445 to 1.8K.
Breakpoint Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Breakpoint Therapeutics's valuation, stock price, and market status.
Is Breakpoint Therapeutics a public or private company?
Breakpoint Therapeutics is a private company.
What is the current stock price of Breakpoint Therapeutics?
Breakpoint Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Breakpoint Therapeutics worth (valuation)?
Valuation information for Breakpoint Therapeutics is not publicly available.
Can I buy Breakpoint Therapeutics stock?
Breakpoint Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Breakpoint Therapeutics's last funding round?
Breakpoint Therapeutics's most recent funding round was Series A Extension on October 18, 2021.
Who are the main investors in Breakpoint Therapeutics?
Key investors in Breakpoint Therapeutics include Medicxi.
Will Breakpoint Therapeutics IPO soon?
No public IPO plans have been announced for Breakpoint Therapeutics.
How can I track Breakpoint Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Breakpoint Therapeutics's secondary market activity and sign up for updates.